Haemostasis 51 , 303306 (1984)
Few articles have additionally recommended the consideration of rapid sequence induction, stating that there should be a low threshold for this method of securing the airway, especially in the setting of uncertainty regarding gastric contents (Joshi 2024
ABSTRACT: Glucagon-like peptide-1 (GLP-1) agonists are a class of medications indicated for type 2 diabetes and obesity that may play a role in the management of cutaneous disease, in part due to their anti-inflammatory effects
10.1097/PSY.0b013e318273bf33 292
Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]
SIRT6 protects genomic stability